Kawai S, Maekawajiri S, Tokunaga K, Kashiwase K, Miyamoto M, Akaza T, Juji T, Yamane A
Institute for Biotechnology Research, Wakunaga Pharmaceutical Co. Ltd, Hiroshima, Japan.
Eur J Immunogenet. 1996 Dec;23(6):471-86. doi: 10.1111/j.1744-313x.1996.tb00137.x.
We describe HLA-DRB1 typing using polymerase chain reaction-based microtitre plate hybridization (PCR-MPH), which can process large numbers of samples. MPH typing is similar to an enzyme-linked immunosorbent assay (ELISA), in which a tandemly ligated sequence-specific oligonucleotide is immobilized on microtitre wells. The typing procedure consisted of two steps. In the first, PCR-MPH with 16 probes was performed to determine the specificities of the serological levels (DR1, DR2, DR3, DR4, DR11, DR12, DR13, DR14, DR7, DR8, DR9 and DR10) after generic amplification ("low resolution typing'). In the second step, DR1, DR2, DR4, DR12/8 and DR3/11/13/14 were group-specifically amplified based on the results of the first PCR-MPH, and microtitre plate hybridization proceeded in a similar manner to the first step ("high resolution typing'). Low resolution typing was completed within 2 h after generic amplification, and the results of high resolution typing were obtained in another 3.5 h after amplification. The allelic types classified using PCR-MPH were completely concordant with those obtained by PCR-single-strand conformation polymorphism or PCR-restriction fragment length polymorphism.
我们描述了使用基于聚合酶链反应的微量滴定板杂交(PCR-MPH)进行HLA-DRB1分型,该方法可处理大量样本。MPH分型类似于酶联免疫吸附测定(ELISA),其中串联连接的序列特异性寡核苷酸固定在微量滴定孔上。分型过程包括两个步骤。第一步,使用16种探针进行PCR-MPH,以在通用扩增(“低分辨率分型”)后确定血清学水平(DR1、DR2、DR3、DR4、DR11、DR12、DR13、DR14、DR7、DR8、DR9和DR10)的特异性。第二步,根据第一次PCR-MPH的结果对DR1、DR2、DR4、DR12/8和DR3/11/13/14进行组特异性扩增,微量滴定板杂交以与第一步类似的方式进行(“高分辨率分型”)。低分辨率分型在通用扩增后2小时内完成,高分辨率分型结果在扩增后另外3.5小时内获得。使用PCR-MPH分类的等位基因类型与通过PCR-单链构象多态性或PCR-限制性片段长度多态性获得的等位基因类型完全一致。